Hutch News

Hutch News

Stories tagged 'Nora Disis'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 3, 2017

Fred Hutch's Dr. Slobodan Beronja and colleagues published new findings that show healthy skin cells can fight off the cancerous tendencies of nearby cells that harbor cancer-causing mutations. Dr. Jeremy Roop, a postdoc conducting HIV research in the McElrath Lab and Computational biology in the Bloom Lab, has been named a Damon Runyan Fellow.

View story >


6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >


New breast cancer vaccine ‘promising but not ready for prime time’

Vaccine potentially could be used in the majority of breast cancer patients

Dec. 3, 2014 | By Diane Mapes / Fred Hutch News Service

They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. Fred Hutch researchers weigh in and discuss their own breast cancer vaccine-related work.

View story >


Cancer Immunotherapy Trials Network selects member sites

Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies

April 11, 2011

Research institutions at 27 sites across North America have been selected as part of the Cancer Immunotherapy Trials Network, based at the Fred Hutchinson Cancer Research Center. A new initiative in immunotherapy, CITN unites top academic immunologists to conduct multicenter research on therapies that boost patients’ own immune systems to fight cancer.

View story >


$17 million award launches Cancer Immunotherapy Trials Network

Center to lead national, multi-institutional clinical trials effort

Oct. 11, 2010

In an effort to accelerate clinical trials of promising cancer immunotherapies, the National Cancer Institute has awarded a five-year, $17 million grant to the Fred Hutchinson Cancer Research Center Clinical Research Division’s Dr. Mac Cheever to establish a new Cancer Immunotherapy Trials Network.

View story >


Removing roadblocks to tumor treatment

Nora Disis and colleagues find promise in expanded T-cell therapy for vaccinated cancer patients with advanced stage tumors

April 9, 2007 | By STEPHANIE CARTIER

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.